Bordalo Ferreira F, Rafael MA, Coimbra L, Boavida N, et al. Anti-tumor necrosis factor therapy is associated with attenuated humoral response to SARS-COV-2 vaccines in patients with inflammatory bowel disease. Vaccine 2023 May 8:S0264-410X(23)00530-3. doi: 10.1016/j.vaccine.2023.
PMID: 37202269